Universal Scientific Industrial (Shanghai) Co., Ltd. (SHA:601231)
China · Delayed Price · Currency is CNY 36.50
+2.65 (7.83%)
At close: Feb 6, 2026
SHA:601231 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 60,249 | 60,615 | 60,730 | 68,470 | 55,254 | 47,672 |
Other Revenue | 75.98 | 75.98 | 62.07 | 45.98 | 46.05 | 24.13 |
| 60,325 | 60,691 | 60,792 | 68,516 | 55,300 | 47,696 | |
Revenue Growth (YoY) | -2.29% | -0.17% | -11.27% | 23.90% | 15.94% | 28.20% |
Cost of Revenue | 54,585 | 54,920 | 55,133 | 61,418 | 50,044 | 42,859 |
Gross Profit | 5,740 | 5,771 | 5,659 | 7,098 | 5,256 | 4,837 |
Selling, General & Admin | 1,755 | 1,780 | 1,557 | 1,719 | 1,453 | 1,320 |
Research & Development | 1,935 | 1,908 | 1,807 | 2,019 | 1,625 | 1,561 |
Other Operating Expenses | 51.51 | 114.13 | 77.36 | 55.43 | 49.82 | 61.71 |
Operating Expenses | 3,787 | 3,834 | 3,463 | 3,804 | 3,133 | 2,935 |
Operating Income | 1,953 | 1,936 | 2,196 | 3,294 | 2,123 | 1,902 |
Interest Expense | -338.57 | -391.01 | -400.22 | -235 | -201.33 | -90.19 |
Interest & Investment Income | 566.55 | 517.75 | 379.23 | 226.63 | 179.46 | 143.89 |
Currency Exchange Gain (Loss) | -215.82 | -215.82 | -32.02 | 136.34 | -62.66 | -63.27 |
Other Non Operating Income (Expenses) | -19.51 | -10.1 | -16.32 | -8.2 | -4.36 | -2.74 |
EBT Excluding Unusual Items | 1,946 | 1,837 | 2,127 | 3,414 | 2,034 | 1,889 |
Gain (Loss) on Sale of Investments | -8.99 | -11.8 | -27.11 | 31.84 | 44.59 | -6.27 |
Gain (Loss) on Sale of Assets | 8.62 | 7.53 | 6.33 | 2.72 | -9.12 | 1.17 |
Asset Writedown | -54.48 | -2.43 | -0.91 | -49.85 | - | - |
Other Unusual Items | 23.36 | 23.36 | 84.73 | 78.43 | 69.25 | 89.32 |
Pretax Income | 1,914 | 1,854 | 2,190 | 3,477 | 2,139 | 1,974 |
Income Tax Expense | 328.34 | 209.65 | 239.98 | 417.21 | 282.17 | 240 |
Earnings From Continuing Operations | 1,586 | 1,644 | 1,950 | 3,060 | 1,857 | 1,734 |
Minority Interest in Earnings | 32.94 | 8.31 | -1.86 | -0.02 | 1.28 | 5.87 |
Net Income | 1,619 | 1,652 | 1,948 | 3,060 | 1,858 | 1,739 |
Net Income to Common | 1,619 | 1,652 | 1,948 | 3,060 | 1,858 | 1,739 |
Net Income Growth | -12.61% | -15.16% | -36.34% | 64.69% | 6.81% | 37.82% |
Shares Outstanding (Basic) | 2,159 | 2,174 | 2,189 | 2,186 | 2,186 | 2,174 |
Shares Outstanding (Diluted) | 2,217 | 2,203 | 2,239 | 2,267 | 2,239 | 2,174 |
Shares Change (YoY) | -0.58% | -1.59% | -1.22% | 1.26% | 2.95% | -0.08% |
EPS (Basic) | 0.75 | 0.76 | 0.89 | 1.40 | 0.85 | 0.80 |
EPS (Diluted) | 0.73 | 0.75 | 0.87 | 1.35 | 0.83 | 0.80 |
EPS Growth | -12.09% | -13.79% | -35.56% | 62.65% | 3.75% | 37.93% |
Free Cash Flow | 2,665 | 2,948 | 5,274 | 1,764 | -2,617 | 380.19 |
Free Cash Flow Per Share | 1.20 | 1.34 | 2.35 | 0.78 | -1.17 | 0.17 |
Dividend Per Share | 0.230 | 0.230 | 0.270 | 0.430 | 0.260 | 0.500 |
Dividend Growth | -14.82% | -14.82% | -37.21% | 65.39% | -48.00% | 185.71% |
Gross Margin | 9.52% | 9.51% | 9.31% | 10.36% | 9.50% | 10.14% |
Operating Margin | 3.24% | 3.19% | 3.61% | 4.81% | 3.84% | 3.99% |
Profit Margin | 2.68% | 2.72% | 3.20% | 4.47% | 3.36% | 3.65% |
Free Cash Flow Margin | 4.42% | 4.86% | 8.67% | 2.57% | -4.73% | 0.80% |
EBITDA | 2,962 | 2,945 | 3,205 | 4,159 | 2,970 | 2,403 |
EBITDA Margin | 4.91% | 4.85% | 5.27% | 6.07% | 5.37% | 5.04% |
D&A For EBITDA | 1,009 | 1,009 | 1,009 | 864.43 | 846.81 | 501.71 |
EBIT | 1,953 | 1,936 | 2,196 | 3,294 | 2,123 | 1,902 |
EBIT Margin | 3.24% | 3.19% | 3.61% | 4.81% | 3.84% | 3.99% |
Effective Tax Rate | 17.15% | 11.31% | 10.96% | 12.00% | 13.19% | 12.16% |
Revenue as Reported | - | - | - | 68,516 | 55,300 | 47,696 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.